Riskpilot← Back to searchSign inGet full accessEDERAGEN HELSE AS
ASActiveOrg 925881945Litleåsvegen 13, 5132 NyborgRetail sale of other food · NACE 4727Est. 20200 employees
Revenue 2024
NOK 2,8M
+171% vs 2023
EBITDA margin
0.0%
-100% vs 2023
Equity ratio
-74.8%
Financial strength
Net profit 2024
NOK 482
-100% vs 2023
| Revenue | NOK 2,8M | +171% |
| EBITDA | NOK 693 | -100% |
| Net profit | NOK 482 | -100% |
| Total assets | NOK 1,9M | +65% |
| Equity | NOK -1,4M | +0% |
| Employees | 0 | — |
Legal name
EDERAGEN HELSE AS
Org number
925881945
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
2. november 2020
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å selge kosttilskudd som motvirker sykdomsdisponerende forstyrrelser i mikrobiologiske og biokjemiske funksjoner i tarm, samt enhver aktivitet som naturlig følger av eller hører sammen med dette, herunder investere i andre selskaper eller i eiendom knyttet til virksomheten.
Address
Litleåsvegen 13, 5132 Nyborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 24 | 257 | 1 024 | 2 771 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −297 | −1 349 | 184 | 1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −297 | −1 349 | 184 | 1 |
| Net financials | 0 | 0 | 0 | −0 |
| Profit before tax | −297 | −1 349 | 184 | 0 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −297 | −1 349 | 184 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 727 | 921 | 1 169 | 1 924 |
| Equity | −273 | −1 623 | −1 439 | −1 439 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 1 000 | 2 544 | 2 608 | 3 363 |
| Total debt | 1 000 | 2 544 | 2 608 | 3 363 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212024
Equity ratio
-74.8%
This company
38.2%
Market median
-296% vs market
20212024
Return on equity
48200.0%
This company
18.4%
Market median
+261857% vs market
20212024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212024
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20212024
Debt / equity
2.34×
This company
0.62×
Market median
-277% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JR | Chairman | 2020 |
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Valand Invest As
EDERAGEN HELSE AS Board members of EDERAGEN HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Eirik Andersen | Chief Executive Officer | 0 companies |
| Jon Trygve Marthinsen | Board of Directors | 0 companies |
| Jan Raa | Chairman | 0 companies |
| Morten Ludvik Isaksen | Board of Directors | 0 companies |
| Hilde Andersen Raa | Board of Directors | 0 companies |
| Einar Andersen Martens | Board of Directors | 0 companies |